Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation.

International journal of oncology

Volumn 16, Issue 6, 2000, Pages 1227-1233

  Mantovani, G ^a   Maccio, A ^a   Massa, E ^a   Mulas, C ^a   Mudu, M C ^a   Massidda, S ^a   Massa, D ^a   Murgia, V ^a   Ferreli, L ^a   Succu, G ^a   Astara, G ^a   Proto, E ^a   Tore, G ^a   Mura, M ^a   Maxia, G ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHASE 2 CLINICAL TRIAL; REMISSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 0034200866     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.16.6.1227     Document Type: Article

References (0)